{"title":"那Somdun改善高脂血症大鼠的肝脏脂肪变性。","authors":"Suchittra Samuhasaneeto, Gorawit Yusakul, Chuchard Punsawad, Kingkan Bunluepuech","doi":"10.1016/j.heliyon.2025.e41671","DOIUrl":null,"url":null,"abstract":"<p><p>Ya That Somdun (YTS) is a traditional Thai medicine composed of six herbs used as a strengthening tonic. Some of the herbs constituting YTS have antihyperlipidemic and anti-obesity activities. The objective of this study was to elucidate the antihyperlipidemic properties of YTS extract in rats with cholesterol suspension-induced hyperlipidemia. Male Sprague-Dawley rats were subdivided into four groups: normal control (NC), hyperlipidemic control (HC), and those who were administered 100 (YTS100) and 200 mg (YTS200) of YTS/kg body weight (BW). Hyperlipidemic rats were orally administered YTS extract for four consecutive weeks from the fifth week of cholesterol suspension. Serum lipid profiles, body weights, liver and renal functional markers, gene expression involved in lipid metabolism, and liver histopathology were examined. The HC and YTS groups showed a significant increase in body weights compared with the NC group. The YTS100 and YTS200 groups showed no significant difference in serum triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels compared with the NC and HC groups. YTS treatment (100 mg/kg BW) downregulated sterol regulatory element binding protein 1c (<i>SREBP-1c</i>) mRNA expression and alleviated hepatic steatosis. In conclusion, the YTS extract reduced hepatic lipid accumulation in hyperlipidemic rats by reducing SREBP-1c expression levels.</p>","PeriodicalId":12894,"journal":{"name":"Heliyon","volume":"11 1","pages":"e41671"},"PeriodicalIF":3.6000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758198/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ya That Somdun improves hepatic steatosis in hyperlipidemic rats.\",\"authors\":\"Suchittra Samuhasaneeto, Gorawit Yusakul, Chuchard Punsawad, Kingkan Bunluepuech\",\"doi\":\"10.1016/j.heliyon.2025.e41671\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ya That Somdun (YTS) is a traditional Thai medicine composed of six herbs used as a strengthening tonic. Some of the herbs constituting YTS have antihyperlipidemic and anti-obesity activities. The objective of this study was to elucidate the antihyperlipidemic properties of YTS extract in rats with cholesterol suspension-induced hyperlipidemia. Male Sprague-Dawley rats were subdivided into four groups: normal control (NC), hyperlipidemic control (HC), and those who were administered 100 (YTS100) and 200 mg (YTS200) of YTS/kg body weight (BW). Hyperlipidemic rats were orally administered YTS extract for four consecutive weeks from the fifth week of cholesterol suspension. Serum lipid profiles, body weights, liver and renal functional markers, gene expression involved in lipid metabolism, and liver histopathology were examined. The HC and YTS groups showed a significant increase in body weights compared with the NC group. The YTS100 and YTS200 groups showed no significant difference in serum triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels compared with the NC and HC groups. YTS treatment (100 mg/kg BW) downregulated sterol regulatory element binding protein 1c (<i>SREBP-1c</i>) mRNA expression and alleviated hepatic steatosis. In conclusion, the YTS extract reduced hepatic lipid accumulation in hyperlipidemic rats by reducing SREBP-1c expression levels.</p>\",\"PeriodicalId\":12894,\"journal\":{\"name\":\"Heliyon\",\"volume\":\"11 1\",\"pages\":\"e41671\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758198/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heliyon\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1016/j.heliyon.2025.e41671\",\"RegionNum\":3,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/15 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heliyon","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1016/j.heliyon.2025.e41671","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
Ya That Somdun (YTS)是一种传统的泰国药物,由六种草药组成,用作加强补品。部分中药具有抗高脂血症和抗肥胖作用。本研究的目的是阐明黄芪提取物对胆固醇悬浮液性高脂血症大鼠的降血脂作用。雄性Sprague-Dawley大鼠分为正常对照组(NC)、高脂血症对照组(HC)和YTS100 /kg体重组(BW)和200 mg /kg体重组(YTS200)。高脂血症大鼠自胆固醇悬浮液第5周起连续4周口服黄芪提取物。检测小鼠血脂、体重、肝肾功能指标、脂质代谢相关基因表达及肝脏组织病理学。与NC组相比,HC组和YTS组的体重显著增加。与NC和HC组相比,YTS100和YTS200组血清甘油三酯、总胆固醇、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)水平无显著差异。YTS处理(100 mg/kg BW)可下调甾醇调节元件结合蛋白1c (SREBP-1c) mRNA表达,减轻肝脏脂肪变性。综上所述,YTS提取物通过降低SREBP-1c表达水平来降低高脂血症大鼠肝脏脂质积累。
Ya That Somdun improves hepatic steatosis in hyperlipidemic rats.
Ya That Somdun (YTS) is a traditional Thai medicine composed of six herbs used as a strengthening tonic. Some of the herbs constituting YTS have antihyperlipidemic and anti-obesity activities. The objective of this study was to elucidate the antihyperlipidemic properties of YTS extract in rats with cholesterol suspension-induced hyperlipidemia. Male Sprague-Dawley rats were subdivided into four groups: normal control (NC), hyperlipidemic control (HC), and those who were administered 100 (YTS100) and 200 mg (YTS200) of YTS/kg body weight (BW). Hyperlipidemic rats were orally administered YTS extract for four consecutive weeks from the fifth week of cholesterol suspension. Serum lipid profiles, body weights, liver and renal functional markers, gene expression involved in lipid metabolism, and liver histopathology were examined. The HC and YTS groups showed a significant increase in body weights compared with the NC group. The YTS100 and YTS200 groups showed no significant difference in serum triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels compared with the NC and HC groups. YTS treatment (100 mg/kg BW) downregulated sterol regulatory element binding protein 1c (SREBP-1c) mRNA expression and alleviated hepatic steatosis. In conclusion, the YTS extract reduced hepatic lipid accumulation in hyperlipidemic rats by reducing SREBP-1c expression levels.
期刊介绍:
Heliyon is an all-science, open access journal that is part of the Cell Press family. Any paper reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards, will be considered for publication. Our growing team of dedicated section editors, along with our in-house team, handle your paper and manage the publication process end-to-end, giving your research the editorial support it deserves.